Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-25 @ 12:01 AM
Ignite Modification Date: 2025-12-25 @ 12:01 AM
NCT ID: NCT01490658
Eligibility Criteria: Inclusion Criteria: * Healthy male and female volunteers (female not pregnant, lactating or breastfeeding) * BMI (Body Mass Index) between 19-29 kg/m\^2, both inclusive * Fasting plasma glucose from 70-115 mg/dl * Subject is judged to be in good health on the basis of their medical history, physical examination, ECG (electrocardiogram), and routine laboratory data Exclusion Criteria: * Any clinically significant disease history, in the opinion of the Investigator, of systemic or organ disease * Clinically significant abnormalities on pre-study clinical examination or any laboratory measurements during screening * Positive results on screening for Hepatitis B surface antigen, Hepatitis C antibody and HIV (human immunodeficiency virus) antibody * Positive results on the drug abuse/alcohol screen * Any regular use of prescription or nonprescription drugs, including mega-vitamin or herbal supplement regimens, other than contraceptives, that cannot be stopped at least 1 week prior to Visit 2 (trial product dose administration) and for the duration of the study * Subject is currently a smoker (more than one cigarette per day or equivalent) * Use of grapefruit or grapefruit juice within 7 days of trial product dose administration * Blood donation, surgery or trauma with significant blood loss (500 mL) within the last 2 months prior to dosing
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Maximum Age: 45 Years
Study: NCT01490658
Study Brief:
Protocol Section: NCT01490658